CARB-X
Tracked across 2 events · 14 articles · First seen Apr 28, 2026 · Last active Jul 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: CARB-X awarded US$2.6 million in funding to AdJane to advance the development of a vaccine candidate for gonorrhea, continuing its mission to combat antibiotic-resistant bacteria.
Apr 28, 2026 · 7 articles
Tech
Impact: CARB-X is supporting an AdJane program against multidrug-resistant Neisseria gonorrhoeae, demonstrating external validation and funding for AdJane's antimicrobial resistance efforts.
Jun 30, 2026 · 7 articles
ERGEN INTELLIGENCE
Track CARB-X live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard